Literature DB >> 9062438

A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.

A G Awad1, L N Voruganti, R J Heslegrave.   

Abstract

The utility of quality of life (QOL) as an evaluative tool in clinical psychiatric research and drug trials could be enhanced by developing appropriate conceptual models of QOL, specific for psychiatric disorders. In our proposed model, QOL of individuals maintained on antipsychotic drug therapy for schizophrenia, is viewed as the subject's perception of the outcome of an interaction between severity of psychotic symptoms, side-effects including subjective responses to antipsychotic drugs, and the level of psychosocial performance. In order to test the validity of the model in clinical setting, we selected a sample of 62 schizophrenic patients clinically stabilized on antipsychotic drug therapy, and measured their subjective QOL and other potentially relevant clinical and psychosocial factors. Standardized scales including the positive and negative syndromes scale (PANSS), abnormal involuntary movements scale (AIMS), Hillside Akathisia scale (HAI), and the social performance schedule (SPS) were used for this purpose. Results of a multiple regression analysis using subjective quality of life as the outcome variable, indicated that severity of schizophrenic symptoms (partial R2 = 0.32, p < 0.0001) and subjective distress caused by akathisia (partial R2 = 0.11, p < 0.01) and neuroleptic dysphoria (partial R2 = 0.06, p < 0.05), accounted for nearly half of the variance, while the contribution from the psychosocial indicators was negligible. These results broadly endorse key aspects of the proposed model, and suggest further studies in this direction. These results experiences during antipsychotic therapy can enhance patients' QOL. This conceptual model has been developed with particular focus on the impact of antipsychotic medications on the QOL of persons with schizophrenia. As such, it is more applicable to clinical trials of new antipsychotic medications but may not be broad enough to be applicable for other social or vocational interventions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062438     DOI: 10.1023/a:1026409326690

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

1.  Quality of life of seriously mentally ill persons in Mississippi.

Authors:  G Sullivan; K B Wells; B Leake
Journal:  Hosp Community Psychiatry       Date:  1991-07

2.  Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.

Authors:  H Y Meltzer; S Burnett; B Bastani; L F Ramirez
Journal:  Hosp Community Psychiatry       Date:  1990-08

3.  The quality of life of chronic patients in a state hospital and in community residences.

Authors:  A F Lehman; S Possidente; F Hawker
Journal:  Hosp Community Psychiatry       Date:  1986-09

Review 4.  Quality of life and clinical trials.

Authors: 
Journal:  Lancet       Date:  1995-07-01       Impact factor: 79.321

5.  A critical appraisal of the quality of quality-of-life measurements.

Authors:  T M Gill; A R Feinstein
Journal:  JAMA       Date:  1994 Aug 24-31       Impact factor: 56.272

6.  "Subjective quality of life": clinical model for assessment of rehabilitation treatment in psychiatry.

Authors:  P Corten; C Mercier; I Pelc
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-07       Impact factor: 4.328

7.  Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis.

Authors:  M M Singh; S R Kay
Journal:  Biol Psychiatry       Date:  1979-04       Impact factor: 13.382

Review 8.  Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life.

Authors:  A G Awad; T P Hogan; L N Voruganti; R J Heslegrave
Journal:  Int Clin Psychopharmacol       Date:  1995-09       Impact factor: 1.659

9.  A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity.

Authors:  T P Hogan; A G Awad; R Eastwood
Journal:  Psychol Med       Date:  1983-02       Impact factor: 7.723

10.  Drugs and the quality of life: the patient's point of view.

Authors:  R Diamond
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

View more
  40 in total

1.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorder II. Predictive value of psychosocial factors.

Authors:  Michael S Ritsner; Marina Arbitman; Alexander Lisker; Alexander M Ponizovsky
Journal:  Qual Life Res       Date:  2011-10-02       Impact factor: 4.147

2.  Subjective quality of life of community living Sudanese psychiatric patients: comparison with family caregivers' impressions and control group.

Authors:  A W Awadalla; J U Ohaeri; A A Salih; A M Tawfiq
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

3.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

4.  Determinants of changes in perceived quality of life in the course of schizophrenia.

Authors:  Michael Ritsner; Anatoly Gibel; Yael Ratner
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

5.  Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.

Authors:  Kun-Po Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2017-12

6.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorders: I. Predictive value of disorder-related factors.

Authors:  Michael S Ritsner; Alexander Lisker; Marina Arbitman
Journal:  Qual Life Res       Date:  2011-09-13       Impact factor: 4.147

7.  Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia.

Authors:  A G Awad
Journal:  J Psychiatry Neurosci       Date:  1997-07       Impact factor: 6.186

Review 8.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

9.  Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients.

Authors:  Yu-Tao Xiang; Yong-Zhen Weng; Chi-Ming Leung; Wai-Kwong Tang; Kelly Y C Lai; Gabor S Ungvari
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

10.  Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study.

Authors:  Krystyna Górna; Krystyna Jaracz; Filip Rybakowski; Janusz Rybakowski
Journal:  Qual Life Res       Date:  2007-12-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.